Brain Tumors
What are Brain Tumors?
Brain tumors are abnormal cell growths in the brain. They can be benign (non-cancerous, slow-growing) such as meningiomas, pituitary adenomas, or schwannomas, or malignant (cancerous, fast-growing) such as glioblastomas, high-grade astrocytomas, or medulloblastomas. Regardless of their nature, these tumors can compress surrounding brain structures and cause severe neurological symptoms. In Tunisia, our neurosurgery and oncology teams are specialized in the management of these complex conditions.
What are the Symptoms of a Brain Tumor?
Symptoms depend on the size, location, and growth rate of the tumor. The most common warning signs include:
- Morning headaches: intense headaches, often present upon waking and improving during the day.
- Seizures: first-time seizures in an adult with no prior history.
- Focal neurological deficits: limb weakness, speech disorders (aphasia), vision loss, balance problems.
- Cognitive or behavioral changes: personality changes, confusion, memory loss.
- Nausea and vomiting without digestive cause, often in the morning.
With these symptoms, a prompt consultation with a neurologist is essential.
How is the Diagnosis Made in Tunisia?
The diagnosis of brain tumors is based on advanced medical imaging:
- 3 Tesla Brain MRI with gadolinium injection: reference examination to visualize the tumor, its size, location, and characteristics (edema, contrast enhancement).
- Perfusion MRI and MR spectroscopy: to differentiate a malignant tumor from a benign lesion or abscess.
- MR angiography: to study tumor vascularization before surgery.
- Stereotactic biopsy: MRI-guided tumor fragment sampling for pathological analysis (definitive diagnosis).
In Tunisia, these tests are available within short timeframes (often less than a week) and at costs much lower than in Europe.
What Treatments are Available?
Brain tumor management is multidisciplinary, involving neurosurgeons, oncologists, radiation therapists, and neuro-anesthesiologists.
Neurosurgery (Tumor Resection)
The goal is to remove the tumor as completely as possible while preserving neurological functions. Our neurosurgeons use advanced techniques: neuronavigation (intraoperative MRI guidance), awake brain mapping (for tumors in language or motor areas), microsurgery, and fluorescence (5-ALA) to better visualize malignant tumor cells.
Radiotherapy
Intensity-modulated radiation therapy (IMRT) and stereotactic radiotherapy (Gamma Knife or CyberKnife) are available to treat inoperable tumor remnants or certain benign tumors (meningiomas, neurinomas).
Chemotherapy and Targeted Therapies
Chemotherapy protocols (temozolomide for glioblastomas) and targeted therapies (bevacizumab) are administered by our oncologists, with close monitoring of side effects.
Symptom Management
Corticosteroids (to reduce cerebral edema), anticonvulsants (seizure prevention), and analgesics.
What are the Risks and Complications?
Like any neurosurgical procedure, brain tumor resection carries risks: post-operative neurological deficit (weakness, speech or vision disorders), cerebral hematoma, infection, cerebral edema, seizures. With neuronavigation techniques and intraoperative monitoring, these risks are significantly reduced. Our neurological intensive care teams are trained to manage these rare complications (less than 5% of cases).
What to Do After Treatment? Follow-up and Rehabilitation
After hospitalization (average duration 7 to 14 days depending on complexity), close follow-up is essential:
- Control MRI at 3 months, then every 6 to 12 months depending on tumor type.
- Neurological rehabilitation: physiotherapy, speech therapy, occupational therapy, psychomotricity if necessary.
- Oncology follow-up for malignant tumors (adjuvant chemotherapy, radiotherapy).
- Psychological support for the patient and family.
Long-term sequelae depend on tumor location and aggressiveness. Our teams support you throughout this care journey.
Why Choose Tunisia for Your Management?
Tunisia has internationally renowned neurosurgeons and neuro-oncologists, trained in the best European and North American centers (France, Belgium, Canada). Equipment is modern: 3 Tesla MRI, neurosurgical operating rooms equipped with neuronavigation, Gamma Knife, advanced radiotherapy services. Management delays are very short (surgery often within 2 to 4 weeks of diagnosis) and costs are up to 60-70% lower than European rates. Our all-inclusive packages include imaging, hospitalization, surgical procedure, radiotherapy/chemotherapy sessions, and immediate post-operative follow-up.